半岛医疗大超炮与逆时针联袂亮相北京 发力高端“械三”赛道

Core Insights - The article highlights the launch of two significant products, the Peninsula Super Cannon and Peninsula Counterclockwise, by Peninsula Medical Group, which recently received NMPA Class III medical device registration [1][3] - These products aim to address deep support and superficial repair in aesthetic medicine, utilizing advanced technology to achieve comprehensive treatment from the fascia layer to the epidermis [1][2] - The company emphasizes its commitment to making advanced medical equipment accessible to thousands of hospitals in China, which were previously dominated by international giants [1] Product Innovations - The Peninsula Golden Microneedle introduces dynamic layered treatment technology, allowing for targeted treatment across five skin layers with a single needle insertion, addressing uneven energy distribution and enhancing patient comfort [2] - The Peninsula Counterclockwise, as the first domestic Class III radiofrequency microneedle, resolves the industry challenge of balancing efficacy and comfort through multi-dimensional technological innovations [2] - The Peninsula Super Cannon, the first globally to receive NMPA Class III certification for focused ultrasound skin treatment, boasts a 50% efficiency improvement and integrates high-resolution ultrasound imaging with treatment processes [3] Market Position and Growth - China is identified as the fastest-growing market for photonic anti-aging treatments, with ultrasound and radiofrequency microneedles accounting for over 60% of the market share [4] - Following its certification, the Peninsula Super Cannon experienced a surge in search interest, indicating strong market potential and consumer engagement [4] - The company has also secured multiple international certifications, including FDA and CE, positioning itself to compete on a global scale and potentially lead in the medical aesthetic device market [4]